Compare Albemarle Corp. (ALB) vs Cassava Sciences Inc (FLNA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Albemarle Corp. vs Cassava Sciences Inc — how do they compare? Albemarle Corp. trades at $131.06 (market cap $15.27B), while Cassava Sciences Inc trades at $0.97 (market cap $47.75M). The key difference: Albemarle Corp. is far larger — about 319.8× Cassava Sciences Inc's market cap, and Albemarle Corp. pays a 1.27% dividend while Cassava Sciences Inc pays none. Which is the better fit depends on your goals.
| ALB | FLNA | |
|---|---|---|
Market Cap | $15.27B | $47.75M |
Sector | Basic Materials | Health |
52-Week High | $215.62 | $4.64 |
52-Week Low | $72.58 | $0.87 |
Enterprise Value | $17.75B | -$34.93M |
Dividend Yield | 1.27% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Albemarle Corp.
Albemarle is the world's largest lithium producer. Our outlook for robust lithium demand is predicated upon increased demand for electric vehicle batteries. Albemarle produces lithium from its salt brine deposits in Chile and the U.S. and its hard rock joint venture mines in Australia. Albemarle is also a global leader in the production of bromine, used in flame retardants. The company is also a major producer of oil refining catalysts.
Read more on ALB →About Cassava Sciences Inc
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →
